Coca-Cola is ‘Already Sponsoring’ Obesity – Why is it Sponsoring Egypt’s COP27? 05/10/2022 Kerry Cullinan The announcement by Egypt’s Ministry of Foreign Affairs that Coca-Cola will sponsor the 27th Annual United Nations Climate Change Conference of the Parties (COP27) has been widely condemned by climate and health activists. The #COP27 Presidency announces The @CocaCola Company as a Supporting Sponsor to COP27. For more information: https://t.co/JDyhS2N79A pic.twitter.com/XRhjoA4i2b — COP27 (@COP27P) September […] Continue reading -> Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> How Can We Ensure that Health is a Reality for Migrants and Refugees? 04/10/2022 Maayan Hoffman After Eugen Ghita arrived in Greece from his native Romania, he did not have a legal residency document, which meant that he did not have access to any kind of public services, including healthcare. “The first two years health was equivalent to having money,” he recalls, sharing his experience during the latest episode of the […] Continue reading -> Shionogi and the Medicines Patent Pool Reach Agreement on COVID-19 Antiviral Pill 04/10/2022 Kerry Cullinan The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
Weak Systems and Lack of Investment in New Antibiotics Are Key Global Health Threats 05/10/2022 Kerry Cullinan Russia’s war in Ukraine is draining resources to build better health systems, while Sino-American rivalry is undermining the global solidarity needed to address future pandemics. But the massive under-investment in new antibiotics to combat drug-resistant “superbugs” and weak primary health systems might be the biggest enemies of global health. This was according to global health […] Continue reading -> One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> How Can We Ensure that Health is a Reality for Migrants and Refugees? 04/10/2022 Maayan Hoffman After Eugen Ghita arrived in Greece from his native Romania, he did not have a legal residency document, which meant that he did not have access to any kind of public services, including healthcare. “The first two years health was equivalent to having money,” he recalls, sharing his experience during the latest episode of the […] Continue reading -> Shionogi and the Medicines Patent Pool Reach Agreement on COVID-19 Antiviral Pill 04/10/2022 Kerry Cullinan The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
One World, One Health – Tackling the Superbug Challenge 04/10/2022 Dame Sally Davies Humans, animals, plants and the environment we all share face escalating risks from antimicrobial resistance (AMR), with the potential for irreversible damage ever more likely. Both our health and the health of the planet are at stake, says a leading champion for more action. We know what to do. One Health thinking has been with […] Continue reading -> How Can We Ensure that Health is a Reality for Migrants and Refugees? 04/10/2022 Maayan Hoffman After Eugen Ghita arrived in Greece from his native Romania, he did not have a legal residency document, which meant that he did not have access to any kind of public services, including healthcare. “The first two years health was equivalent to having money,” he recalls, sharing his experience during the latest episode of the […] Continue reading -> Shionogi and the Medicines Patent Pool Reach Agreement on COVID-19 Antiviral Pill 04/10/2022 Kerry Cullinan The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
How Can We Ensure that Health is a Reality for Migrants and Refugees? 04/10/2022 Maayan Hoffman After Eugen Ghita arrived in Greece from his native Romania, he did not have a legal residency document, which meant that he did not have access to any kind of public services, including healthcare. “The first two years health was equivalent to having money,” he recalls, sharing his experience during the latest episode of the […] Continue reading -> Shionogi and the Medicines Patent Pool Reach Agreement on COVID-19 Antiviral Pill 04/10/2022 Kerry Cullinan The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
Shionogi and the Medicines Patent Pool Reach Agreement on COVID-19 Antiviral Pill 04/10/2022 Kerry Cullinan The Medicines Patent Pool (MPP) has signed a voluntary licence agreement with Japanese pharmaceutical company, Shionogi, to enable generic companies to produce its COVID-19 antiviral treatment pill candidate, provided it gets regulatory approval. The pill, ensitrelvir fumaric acid, has already shown efficacy in a phase 2/ 3 trial involving 1,821 COVID-19 patients from Japan, South […] Continue reading -> Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
Boost for Mali Civilian Health Protections 01/10/2022 Elaine Ruth Fletcher Leaders of a coalition of former Tuareg and Arab rebels in Mali signed a written pledge on civilian protections for health and medical facilities during armed conflict, reflecting global efforts to stem attacks on health facilities, transport, and patients that have became more frequent since the onset of the COVID-19 crisis. The two leaders with […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
EU to Release Communication on Second Global Health Strategy Plan by December 29/09/2022 Stefan Anderson “This is really a historic meeting,” said Dr Ilona Kickbusch, co-chair of the European Health Forum at Gastein (EHFG). “Twenty years ago was the very first time there was any talk of a European global health strategy, and it took place right here at Gastein.” “It was in 2003 that global health first became a part […] Continue reading -> From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
From Equity to Conspiracies, People Say What They Want From a Pandemic Treaty 29/09/2022 Kerry Cullinan From bedrooms in China to boardrooms in Geneva, people offered their views on how to protect the world against future pandemics during the second round of public hearings called by the World Health Organization (WHO). The public hearings are part of the WHO intergovernmental negotiating board (INB) process to develop a pandemic “convention, agreement or […] Continue reading -> Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts
Africa’s New Medicine Agency Needs Support From Continent’s Powerhouses 28/09/2022 Kerry Cullinan Africa’s most powerful countries need to ratify the African Medicines Agency (AMA) to ensure its credibility – and civil society organisations can lobby them to do so , said Dr Michel Sidibe, the African Union’s (AU) Special Representative on the AMA. “It is important to have countries like South Africa, Nigeria, Kenya, Ethiopia, the DRC, […] Continue reading -> Posts navigation Older Posts Newer Posts